Tibra Equities Europe’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-18,200
Closed -$287K 457
2019
Q1
$287K Buy
+18,200
New +$287K 0.03% 340